Efficacy of bretazenil against cortical epileptic afterdischarges increases during early ontogeny in rats

Pharmacological Reports

Volumn 58, Issue 4, 2006, Pages 519-525

  Mareš, Pavel ^a   Šlamberová, Romana ^a,b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Benzodiazepine partial agonist; Cerebral cortex; Epileptic afterdischarges; Ontogeny; Rat

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BRETAZENIL; CLONAZEPAM; MIDAZOLAM; SOLVENT;

AFTERDISCHARGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; ELECTRODE; EPILEPSY; EPILEPTIC DISCHARGE; GROUPS BY AGE; NERVE STIMULATION; NEWBORN; NONHUMAN; ONTOGENY; RAT; SENSORIMOTOR CORTEX;

EID: 33748670495     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Avanzini G, de Curtis M, Marescaux C, Panzica F, Spreafico R, Vergnes M: The role of thalamic reticular nucleus in the generation of thalamo-cortical activities subserving spike and waves. J Neural Transm, 1992, Suppl 35, 85-95.
2. Basile AS, Lippa AS, Skolnick P: Anxioselective anxiolytics: can less be more? Eur J Pharmacol, 2004, 500, 441-451.
3. Bernášková K, Šlamberová R, Mareš P: GABA uptake blocker NNC-711 exhibits marked anticonvulsant action in two cortical epileptic models in immature rats. Epilepsia, 1999, 40, 1184-1189.
4. Brabcová R, Kubová H, Velíšek L, Mareš P: Effects of a benzodiazepine, bretazenil (Ro 16-6028), on rhythmic metrazol EEG activity: comparison with standard anticonvulsants. Epilepsia, 1993, 34, 1135-1140.
5. Browne TR, Penry JK: Benzodiazepines in the treatment of epilepsy. Epilepsia, 1973, 14, 277-310.
6. Browning RA, Nelson DK: Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp Neurol, 1986, 93, 546-556.
7. Della Paschoa OE, Kruk MR, Hamstra R, Voskuyl RA, Danhof M: Seizure patterns in kindling and cortical stimulation models of experimental epilepsy. Brain Res, 1997, 770, 221-227.
8. Dyer RS, Swartzwelder HS, Eccles CU, Annau Z: Hippocampal afterdischarges and their post-ictal sequelae in rats: A potential tool for assessment of CNS neurotoxicity. Neurobehav Toxicol, 1979, 1, 5-19.
9. Eadie MJ, Vajda FJE (Ed.): Antiepileptic Drugs. Pharmacology and Therapeutics. Springer, Berlin, 1999.
10. Haeffely W: Partial agonists of the benzodiazepine receptor: from animal data to results in patients. In: Chloride Channels and Their Modulation by Neurotransmitters and Drugs. Ed. Biggio G, Costa E, Raven Press, New York, 1988, 275-292.
11. Haefely W, Martin JR, Schoch P: Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci, 1990, 11, 452-456.
12. Heinemann U, Jones RSG: Neurophysiology. In: Comprehensive Epileptology. Ed. Dam M, Gram L, Raven Press, New York, 1990, 17-42.
13. Hoogerkamp A, Arends RH, Bomers AM, Mandema JW, Voskuyl RA, Danhof M: Pharmacokinetic-pharmacodynamic relationship of benzodiazepines in the direct cortical stimulation model of anticonvulsant effect. J Pharmacol Exp Ther, 1996, 279, 803-812.
14. Jacobson M: Developmental Neurobiology, 3rd edn., Plenum Press, New York, 1991.
15. Jenck F, Moreau J-L, Bonetti EP, Martin JR, Haefely WE: Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of potential anxiolytic. J Pharmacol Exp Ther, 1992, 262, 1121-1127.
16. Kubová H, Lanštiaková M, Mocková M, Mareš P, Vorlíček J: Pharmacology of cortical epileptic afterdischarges in rats. Epilepsia, 1996, 37, 336-341.
17. Kubová H, Makal V, Miňová M, Vaňková S, Mareš P: Influence of clonazepam on cortical epileptic afterdischarges in rats. Arch Int Pharmacodyn, 1990, 307, 49-59.
18. Kubová H, Mareš P: Time course of the anticonvulsant action of clonazepam in the developing rats. Arch Int Pharmacodyn, 1989, 298, 15-24.
19. Kubová H, Mareš P: The effect of ontogenetic development on the anticonvulsant activity of midazolam. Life Sci, 1992, 50, 1665-1672.
20. Kubová H, Mareš P, Vorliček J: Stable anticonvulsant action of benzodiazepines during development in rats. J Pharm Pharmacol, 1993, 45, 807-810.
21. Kubová H, Mikulecká A, Haugvicová R, Mareš P: The benzodiazepine receptor partial agonist Ro 19-8022 suppresses generalized seizures without impairing motor functions in developing rats. Naunyn Schmiedebergs Arch Pharmacol, 1999, 360, 565-574.
22. Kubová H, Rathouská J, Mareş P: Anticonvulsant effects of bretazenil (Ro 16-6028) during ontogenesis. Epilepsia, 1993, 34, 1130-1134.
23. Löscher W, Schwark WS: Development of tolerance to the anticonvulsant effect of diazepam in amygdalakindled rats. Exp Neurol, 1985, 90, 373-384.
24. Mareš P: Anticonvulsant action of three neurosteroids against cortical epileptic afterdischarges in immature rats. Brain Res Bull, 2005, 68, 179-184.
25. Mareš P, Folbergrová J, Kubová H: Excitatory aminoacids and epilepsy seizures in immature brain. Physiol Res, 2004, 53, Suppl 1, S115-S124.
26. Mareš P, Haugvicová R, Kubová H: Unequal development of thresholds for various phenomena induced by cortical stimulation in rats. Epilepsy Res, 2002, 49, 35-43.
27. Martin JR, Pieri L, Bonetti EP, Schaffner R, Burkard WP, Cumin R, Haefely WE: Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor. Pharmacopsychiatry, 1988, 21, 360-362.
28. Racine RJ: Modification of seizure activity by electrical stimulation: II. Motor seizures. Electroenceph Clin Neurophysiol, 1972, 32, 281-294.
29. Rosenberg HC, Tietz EI, Chiu TH: Tolerance to anticonvulsant effects of diazepam, clonazepam and clobazam in amygdala-kindled rats. Epilepsia, 1989, 30, 276-285.
30. Rundfeldt C, Wlaz P, Honack D, Löscher W: Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil. J Pharmacol Exp Ther, 1995, 275, 693-702.
31. Schoch P, Moreau JL, Martin JR, Haefely WE: Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence. Biochem Soc Symp, 1993, 59, 121-134.
32. Šlamberová R, Mareš P: Cortical epileptic afterdischarges in immature rats are differently influenced by NMDA receptor antagonists. Eur J Pharmacol, 2005, 516, 10-17.
33. Šlamberová R, Mareš P, Vorlíček J: Clobazam exerts an anticonvulsant action in immature rats. Physiol Res, 1998, 47, 301-305.
34. Smith MA, Craig CK, French AM: Agonist and antagonist effects of benzodiazepines on motor performance: influence of intrinsic efficacy and task difficulty. Behav Pharmacol, 2004, 15, 215-223.
35. Snead OC: Pharmacological models of generalized absence seizures in rodents. J Neural Transm, 1992, Suppl 35, 7-19.
36. Steru L, Chermat R, Millet B, Mico JA, Simon P: Comparative study in mice of ten 1,4-benzodiazepines and of clobazam: anticonvulsant, anxiolytic, sedative, and myorelaxant effects. Epilepsia, 1986, 27, Suppl 1, S14-S17.
37. Vernadakis A: Spinal cord convulsions in developing rats. Science, 1962, 137, 532.
38. Voskuyl RA, Dingmanse J, Danhof M: Determination of the threshold for convulsions by direct cortical stimulation. Epilepsy Res, 1989, 3, 120-129.
39. Walton NY, Treiman DM: Motor and electrographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam. Brain Res, 1991, 553, 97-104.